08. 04. 2022

As the iPAAC JA has come to the end, we would like to thank all the partners of the Consortium, our very special thanks go to the Work Package Leaders, who have done a lot of the groundwork in their respective specialised areas. We could not have achieved this much without the strong commitment, dedicated work, and efforts of all partners in the consortium in reaching our joint objectives and completing our deliverables.

Moreover, we would like to draw your attention to some of the key results and activities that were running under each of the Work Packages and have contributed to the different actions, which have already been launched. Many of the WP outputs represent an important stepping stone for the development of further actions in the field of cancer control. We are confident that several of our actions and deliverables will importantly contribute to the implementation of the Europe’s Beating Cancer Plan.

The major result of iPAAC JA is reflected in the innovative tool - Roadmap on Implementation and Sustainability of Cancer Control Actions (https://www.ipaac.eu/roadmap/), which is intended to facilitate the implementation of cancer control actions in Member States. The iPAAC Roadmap represents the concrete and practical results of the iPAAC JA, drawing together the information generated and collected during the last 10 years by the EU cancer control consortiums. We believe that the most important added value of the iPAAC JA Roadmap is that it represents a unique source of information based on concrete examples, which have been applied in EU countries, to overcome specific cancer control implementation problems. Moreover, the Roadmap has the potential to be a living document, with constant updates and can be transferred to a more institutional setting or updated with documents and reports from future projects and initiatives, ensuring sustainability in the long-term.

We have produced also Layman version of the final report for the iPAAC JA, which aims to summarize in a brief manner the objectives, developments, outcomes and deliverables of the iPAAC JA.

It is significant that there have been confirmed forthcoming initiatives on cancer funded by HaDEA, as the legacy of the previous three cancer Joint Actions and network of experts can be sustained in future years and upgraded with new and more ambitious objectives. Many of the partners are indeed very much looking forward to positively contribute to the next JA on cancer control – CRANE JA. We are confident that positive atmosphere that has prevailed in the current JA will serve as a good foundation to continue jointly working towards the improved cancer control in Europe.